search
NASDAQ:ADAP
USD
1.1
- (-4.3%)
ADAPTIMMUNE THERAPEUTICS PLC
Industry: Biotechnology
End of Day: 7 May 2024 GMT-4
USD 1.100
- (-4.3%)
End of Day: 7 May 2024 GMT-4
Industry: Biotechnology

Quote

Market Cap
-
1M Daily Avg. Vol
-
3Y P/B Range
-
52W Range
-
3Y P/S Range
-
3Y DivYield Range
-

Company Info

more

Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive pro...

Key Ratios

more

Income

more

Balance Sheet

more

Cash Flow

more

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices